Aminobenzenesulfonic auristatin E
Aminobenzenesulfonic auristatin E is a agent-linker conjugate for ADC. Aminobenzenesulfonic auristatin E has potent antitumor activity by using Auristatin E (a cytotoxic tubulin modifier), linked via the ADC linker Aminobenzenesulfonic[1].
Product Specifications
CAS Number
[1800462-99-0]
UNSPSC
12352203
Target
Drug-Linker Conjugates for ADC; Microtubule/Tubulin
Type
ADC Related
Related Pathways
Antibody-drug Conjugate/ADC Related; Cell Cycle/DNA Damage; Cytoskeleton
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/aminobenzenesulfonic-auristatin-e.html
Solubility
DMSO : 330 mg/mL (ultrasonic)
Smiles
C[C@@H](C(N[S](=O)(C(C=C1)=CC=C1N)=O)=O)[C@H]([C@@](CCC2)([H])N2C(C[C@@H](OC)[C@H]([C@@H](C)CC)N(C)C([C@H](C(C)C)NC([C@@H](N(C)C)C(C)C)=O)=O)=O)OC
Molecular Formula
C37H64N6O8S
Molecular Weight
753.00
References & Citations
[1]Kevin HAMBLETT, et al. Anti-her2 biparatopic antibody-drug conjugates and methods of use. Patent WO2019173911A1.
Shipping Conditions
Room temperature
Scientific Category
ADC Related
Clinical Information
No Development Reported
Isoform
Auristatin
Explore Other Products
Browse additional items from our catalog
LPL (Lipoprotein lipase) (11S12) Mouse Monoclonal antibody
Sprouty 2 (SPRY2) Human qPCR Template Standard (NM_005842)
Cmas sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)